Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133580
Filing Date
2022-04-29
Accepted
2022-04-29 16:06:54
Documents
14
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d294152ddef14a.htm DEF 14A 587665
2 GRAPHIC g294152g03a11.jpg GRAPHIC 44141
3 GRAPHIC g294152g04h20.jpg GRAPHIC 21458
4 GRAPHIC g294152g07t86.jpg GRAPHIC 22504
5 GRAPHIC g294152g18a23.jpg GRAPHIC 62648
6 GRAPHIC g294152g24s24.jpg GRAPHIC 1689
7 GRAPHIC g294152g25s25.jpg GRAPHIC 1754
8 GRAPHIC g294152g45u65.jpg GRAPHIC 45140
9 GRAPHIC g294152g46x70.jpg GRAPHIC 64860
10 GRAPHIC g294152g65n26.jpg GRAPHIC 58761
11 GRAPHIC g294152g91s91.jpg GRAPHIC 2940
12 GRAPHIC g294152g93s93.jpg GRAPHIC 3509
13 GRAPHIC g294152g96z76.jpg GRAPHIC 66007
14 GRAPHIC g294152recorddate.jpg GRAPHIC 55517
  Complete submission text file 0001193125-22-133580.txt   1202357
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37844 | Film No.: 22875249
SIC: 3841 Surgical & Medical Instruments & Apparatus